Ipca Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,392.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.42 per cent from ₹2,556.50 crore. This corresponds to a year-on-year *(YoY) growth of 6.55 per cent.
Operating Profit
Operating Profit stands at ₹533.35 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.59 per cent from ₹486.66 crore. This corresponds to a year-on-year *(YoY) growth of 15.17 per cent.
PBDT
PBDT stands at ₹553.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.45 per cent from ₹491.94 crore. This corresponds to a year-on-year *(YoY) growth of 18.86 per cent.
Profit Before Tax
Profit Before Tax stands at ₹445.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.67 per cent from ₹388.61 crore. This corresponds to a year-on-year *(YoY) growth of 21.43 per cent.
Net Profit
Net Profit stands at ₹363.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.64 per cent from ₹280.53 crore. This represents a 31.59 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Ipca Laboratories Ltd News
Ipca Laboratories Ltd Earnings
- YOY
- QOQ
Ipca Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Ipca Laboratories Ltd Research Reports
Ipca Laboratories Ltd Financial Reports
Ipca Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ipca Labs. | 0.16% | -4.29% | 2.49% | 2.89% | 13.04% | 7.70% |
| Alkem Lab | -0.37% | -1.08% | 0.59% | -4.59% | -5.50% | 2.29% |
| Abbott India | -0.35% | 0.63% | 8.52% | 4.25% | -6.21% | -9.25% |
| Anthem Bioscienc | 1.03% | -0.96% | 0.34% | 10.28% | 23.24% | 5.81% |
| Glaxosmi. Pharma | -0.73% | -2.75% | -6.62% | -11.16% | -9.37% | -26.79% |
| Ajanta Pharma | 0.54% | -3.21% | 10.05% | 3.10% | 21.96% | 19.45% |
| Gland Pharma | -1.01% | 3.98% | 30.20% | 26.65% | 30.20% | 51.02% |
Company Info
Company Information
Executive Chairman : Premchand Godha
Managing Director & CFO : A K Jain
Managing Director & Chief Executive Officer : Pranay Godha
Executive Director : Prashant Godha
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Narendra Mairpady
Company Sec. & Compli. Officer : Harish P Kamath
Independent Director : Swati Patankar
Independent Director : Vivek Shiralkar